PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

#EU

Tag

Windsor Framework returns NI medicines control to UK

Windsor Framework returns NI medicines control to UK

The recently announced Windsor Framework seeks to restore Northern Ireland’s position as part of the UK and thereby undo the political, economic and societal challenges brought about by two years under the Northern Ireland Protocol. As over 1,700 pages of EU law will no longer apply in the region, what will be the situation for medicines supply once the deal goes through, and how will greater cooperation with the EU impact research and innovation under Horizon Europe?

20 Mar 2023
Read More
EMA publishes overview of medicines recommended in 2022

EMA publishes overview of medicines recommended in 2022

The European Medicines Agency (EMA) has published its key recommendations for marketing authorisations in 2022 in ‘Human Medicines Highlights 2022’.

21 Feb 2023
Read More
EC adopts proposal to allow more time to certify medical devices

EC adopts proposal to allow more time to certify medical devices

Fears of a shortage of medical devices have led the European Commission (EC) to adopt a proposal to extend the transition period to new rules under the Medical Devices Regulation. The proposal was made at the EPSCO Council meeting on 9 December 2022 by EU health ministers.

23 Jan 2023
Read More
EMA and ECDC collaborate on vaccine safety and effectiveness monitoring studies

EMA and ECDC collaborate on vaccine safety and effectiveness monitoring studies

The European Medicines Agency (EMA) and European Centre for Disease Prevention and Control (ECDC) held the first meeting of the Immunisation and Vaccine Monitoring Advisory Board (IVMAB) of the Vaccine Monitoring Platform (VMP) in early December. Via the VMP they will coordinate and oversee EU-funded, independent post-authorisation studies on vaccines use, safety and effectiveness in EU countries.

30 Dec 2022
Read More
European Union’s share of global medicine R&D shrinks by 25% in 20 years

European Union’s share of global medicine R&D shrinks by 25% in 20 years

A report commissioned by the European Federation of Pharmaceutical Industries and Associations (EFPIA) has led the organisation to warn that the options being discussed by policymakers around the EU Pharma Strategy fall short.

25 Nov 2022
Read More

Categories

  • Awards
  • Consultants
  • Events
  • News
    • General
    • Medical Affairs
    • Rare diseases
  • Our Services
  • Regulatory
  • Resources
    • White Paper

Tags

#ABPI #ClinicalTrials #diagnostics #drugdevelopment #drugpricing #drugregulation #EC #EMA #EU #FDA #innovation #JPMorgan #lifesciences #marketaccess #MDR #medicalaffairs #medicaldevice #medicaldeviceregulation #medicaldevicesregulation #medtech #mentalhealth #mhra #NHS #NICE #outsourcing #pharmaregulation #pharmatrends #pre-eclampsia #R&D #raredisease #rarediseases #regulation #regulatory #UKgovernment #ukpharma #ukregulation #VPAS @PPharmamedic AI Biotech COVID-19 Healthcare Medical Affairs medicaldevices Pharma
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital